Postoperative survival in intrahepatic cholangiocarcinoma showing intraductal growth

Hepato-Gastroenterology

Volumn 52, Issue 62, 2005, Pages 374-377

  Hai, Seikan ^a   Kubo, Shoji ^a   Uenishi, Takahiro ^a   Yamamoto, Takatsugu ^a   Tanaka, Hiromu ^a   Shuto, Taichi ^a   Takemura, Shigekazu ^a   Hirohashi, Kazuhiro ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Intraductal growth type; Intrahepatic cholangiocarcinoma

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CANCER RECURRENCE; CANCER SURVIVAL; CAROLI DISEASE; CASE REPORT; CHOLANGITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; EPIGASTRIC PAIN; FEMALE; FEVER; HUMAN; INTRAHEPATIC CHOLANGIOCARCINOMA; JAUNDICE; LIVER RESECTION; LYMPH NODE DISSECTION; MALE; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME;

BILE DUCTS; CHOLANGIOCARCINOMA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; POSTOPERATIVE PERIOD; SURVIVAL ANALYSIS;

EID: 16344383679     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. The Liver Cancer Study Group of Japan: Classification of primary liver cancer. 1st English Edition. Tokyo: Kanahara, 1997.
2. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M: Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 1998; 69:162-167.
3. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, Miyazaki M: Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg 2002; 89:1525-1531.
4. Suh KS, Chang SH, Lee HJ, Roh HR, Kim SH, Lee KU: Clinical outcomes and apomucin expression of intrahepatic cholangiocarcinoma according to gross morphology. J Am Coll Surg 2002; 195:782-789.
5. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H: Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999; 6:108-116.
6. Hirohashi K, Uenishi T, Kubo S, Yamamoto T, Tanaka H, Shuto T, Kinoshita H: Macroscopic types of intrahepatic cholangiocarcinoma: clinicopathologic features and surgical outcomes. Hepatogastroenterology 2002; 49:326-329.
7. Suh KS, Roh HR, Koh YT, Lee KU, Park YH, Kim SW: Clinicopathologic features of the intraductal growth type of peripheral cholangiocarcinoma. Hepatology 2000; 31:12-17.
8. Chen MF, Jan YY, Chen TC: Clinical studies of mucin-producing cholangiocellular carcinoma: a study of 22 histopathology-proven cases. Ann Surg 1998; 227:63-69.
9. The Liver Cancer Study Group of Japan: Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990; 211:277-287.
10. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V: Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev 1993; 2:537-544.
11. Chen MF: Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment. J Gastroenterol Hepatol 1999; 14:1144-1149.
12. Sano T, Kamiya J, Nagino M, Uesaka K, Kondo S, Kanai M, Hayakawa N, Nimura Y: Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999; 6:101-107.
13. Itamoto T, Asahara T, Katayama K, Nakahara H, Fukuda T, Yano M, Hino H, Nakahara M, Dohi K, Shimamoto F: Hepatic resection for intrahepatic cholangiocarcinoma: relation to gross tumor morphology. Hepatogastroenterology 2001; 48:1129-1133.
14. Jan YY, Jeng LB, Hwang TL, Wang CS, Chen MF, Chen TJ: Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology 1996; 43:614-619.
15. Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF, Belghiti J: Resection of intrahepatic cholangiocarcinoma: a Western experience. J Hepatobiliary Pancreat Surg 1999; 6:122-127.
16. Roayaie S, Guarrera JV, Ye MQ, Thung SN, Emre S, Fishbein TM, Guy SR, Sheiner PA, Miller CM, Schwartz ME: Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg 1998; 187:365-372.
17. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Hamba H, Tanaka H, Kinoshita H: Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg 2001; 25:865-869.
18. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Konishi M, Kinoshita T, Miyagawa S, Kawasaki S: Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000; 127:498-505.
19. Gerhards MF, van Gulik TM, Gonzalez Gonzalez D, Rauws EA, Gouma DJ: Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 2003; 27:173-179.
20. Isa T, Kusano T, Shimoji H, Takeshima Y, Muto Y, Furukawa M: Predictive factors for long-term survival in patients with intrahepatic cholangiocarcinoma. Am J Surg 2001; 181:507-511.